• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

墨西哥城 COVID-19 大流行第一波期间医护人员感染 SARS-CoV-2 后的抗体反应特征。

Features of antibody responses after SARS-COV-2 infection in healthcare workers in the first wave of COVID-19 pandemic in Mexico City.

机构信息

Laboratorio de Medicina Genómica, Hospital Regional "1° de Ocutbre", Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico.

Scientific Management of KPC Biotech. California, USA.

出版信息

J Int Med Res. 2022 Jul;50(7):3000605221099458. doi: 10.1177/03000605221099458.

DOI:10.1177/03000605221099458
PMID:35879824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9340344/
Abstract

OBJECTIVE

To investigate the antibody response to SARS-CoV-2 and identify associated factors in frontline and second-line healthcare workers (HCWs) at a large hospital in Mexico City during the first wave of COVID-19 pandemic.

METHODS

This was a cross-sectional study of HCWs returning to work following mandatory isolation after recovering from COVID-19. Immunoglobulin (Ig) M and IgG antibodies elicited by SARS-CoV-2 were semiquantitatively measured using densitometric analysis of band intensities in lateral flow assay (LFA) devices. The mean pixel intensity (dots-per-inch [dpi]) of each band on the LFA was considered a measure of antibody titre.

RESULTS

Of the 111 HCWs involved in the study, antibody responses were detected in 73/111 (66%) participants. Severe COVID symptoms was associated with old age. No differences in IgM intensity were observed between men and women, but IgG intensity was significantly higher in men than in women. Second-line HCWs produced a higher IgG intensity than firstline HCWs. The IgG intensity was high in severe cases.

CONCLUSIONS

For HCWs who may acquire SARS-CoV-2 infection, it is necessary to establish a routine program for detection of the virus to avoid risk of infection and spread of COVID-19.

摘要

目的

在墨西哥城一家大型医院的 COVID-19 大流行第一波期间,调查一线和二线医护人员(HCW)对 SARS-CoV-2 的抗体反应,并确定相关因素。

方法

这是一项横断面研究,对从 COVID-19 中康复后强制隔离后返回工作岗位的 HCW 进行研究。使用侧向流动分析(LFA)设备中带强度的密度分析半定量测量 SARS-CoV-2 引起的免疫球蛋白(Ig)M 和 IgG 抗体。LFA 上每条带的平均像素强度(每英寸点数 [dpi])被认为是抗体滴度的衡量标准。

结果

在参与研究的 111 名 HCW 中,有 73/111(66%)的参与者检测到抗体反应。严重的 COVID 症状与年龄较大有关。男性和女性之间的 IgM 强度没有差异,但男性的 IgG 强度明显高于女性。二线 HCW 产生的 IgG 强度高于一线 HCW。重症病例的 IgG 强度较高。

结论

对于可能感染 SARS-CoV-2 的 HCW,有必要建立常规的病毒检测程序,以避免 COVID-19 的感染和传播风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d6/9340344/e8b821713348/10.1177_03000605221099458-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d6/9340344/e88395bed51e/10.1177_03000605221099458-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d6/9340344/3b408ac0b874/10.1177_03000605221099458-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d6/9340344/e8b821713348/10.1177_03000605221099458-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d6/9340344/e88395bed51e/10.1177_03000605221099458-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d6/9340344/3b408ac0b874/10.1177_03000605221099458-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d6/9340344/e8b821713348/10.1177_03000605221099458-fig3.jpg

相似文献

1
Features of antibody responses after SARS-COV-2 infection in healthcare workers in the first wave of COVID-19 pandemic in Mexico City.墨西哥城 COVID-19 大流行第一波期间医护人员感染 SARS-CoV-2 后的抗体反应特征。
J Int Med Res. 2022 Jul;50(7):3000605221099458. doi: 10.1177/03000605221099458.
2
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.在 COVID-19 大流行的第一波和第二波期间,一家三级癌症中心的癌症患者和医护人员中 SARS-CoV-2 抗体的血清阳性率的平行进化和差异:canSEROcov-II 横断面研究。
Eur J Cancer. 2022 Apr;165:13-24. doi: 10.1016/j.ejca.2022.01.005. Epub 2022 Feb 1.
3
Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland.爱尔兰南部一家三级医院在 COVID-19 大流行第一波后医护人员中 SARS-CoV-2 抗体的血清阳性率研究。
BMJ Open. 2021 Jun 8;11(6):e051415. doi: 10.1136/bmjopen-2021-051415.
4
Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.日本 COVID-19 大流行期间癌症患者与医护人员间 SARS-CoV-2 抗体状态的差异。
JAMA Oncol. 2021 Aug 1;7(8):1141-1148. doi: 10.1001/jamaoncol.2021.2159.
5
SARS-CoV-2 Seroprevalence among the Health Care Staff of an Ophthalmological Reference Centre, a Cross Sectional Study.SARS-CoV-2 血清抗体在眼科参考中心医护人员中的流行率:一项横断面研究。
Ophthalmic Epidemiol. 2022 Oct;29(5):483-490. doi: 10.1080/09286586.2021.1974493. Epub 2021 Sep 16.
6
Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.智利一家三级医院在新冠疫情第一波期间对一线医护人员的 SARS-CoV-2 IgG 血清阳转进行的纵向评估。
BMC Infect Dis. 2021 May 26;21(1):478. doi: 10.1186/s12879-021-06208-2.
7
SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves.SARS-CoV-2 血清抗体阳性率在第一波和第二波大流行后医护人员中的情况。
Viruses. 2022 Jul 14;14(7):1535. doi: 10.3390/v14071535.
8
Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.波兰一家儿科三级医院医护人员中针对 SARS-CoV-2 的 IgG 抗体流行率。
PLoS One. 2021 Apr 1;16(4):e0249550. doi: 10.1371/journal.pone.0249550. eCollection 2021.
9
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.印度医护人员中 SARS-CoV-2 抗体的血清阳性率及其对感染控制实践的影响。
Indian J Med Res. 2021;153(1 & 2):207-213. doi: 10.4103/ijmr.IJMR_3911_20.
10
Seroprevalence, infection, and personal protective equipment use among Colombian healthcare workers during the COVID-19 pandemic.哥伦比亚医护人员在 COVID-19 大流行期间的血清流行率、感染率和个人防护设备使用情况。
Front Public Health. 2023 Oct 10;11:1225037. doi: 10.3389/fpubh.2023.1225037. eCollection 2023.

本文引用的文献

1
Monoclonal antibody pairs against SARS-CoV-2 for rapid antigen test development.针对 SARS-CoV-2 的单克隆抗体对,用于快速抗原检测开发。
PLoS Negl Trop Dis. 2022 Mar 31;16(3):e0010311. doi: 10.1371/journal.pntd.0010311. eCollection 2022 Mar.
2
Antibody Responses in COVID-19: A Review.新型冠状病毒肺炎中的抗体反应:综述
Front Immunol. 2021 Apr 15;12:633184. doi: 10.3389/fimmu.2021.633184. eCollection 2021.
3
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19.COVID-19 进程中 IgM 和 IgG 的血清阳性率和动力学。
BMC Immunol. 2021 Feb 17;22(1):14. doi: 10.1186/s12865-021-00404-0.
4
Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.西班牙6000多名医护人员中新型冠状病毒2型抗体的血清阳性率
Int J Epidemiol. 2021 May 17;50(2):400-409. doi: 10.1093/ije/dyaa277.
5
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.个体医护人员中严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)抗体反应的持续时间、动态变化和决定因素。
Clin Infect Dis. 2021 Aug 2;73(3):e699-e709. doi: 10.1093/cid/ciab004.
6
Antibody response to SARS-CoV-2 infection in humans: A systematic review.人类对 SARS-CoV-2 感染的抗体反应:系统综述。
PLoS One. 2020 Dec 31;15(12):e0244126. doi: 10.1371/journal.pone.0244126. eCollection 2020.
7
The Importance and Challenges of Identifying SARS-CoV-2 Reinfections.识别新冠病毒再次感染的重要性与挑战
J Clin Microbiol. 2021 Mar 19;59(4). doi: 10.1128/JCM.02769-20.
8
Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection.无症状或轻症 SARS-CoV-2 感染 8 个月后的抗体反应。
Emerg Infect Dis. 2021 Mar;27(3):928-931. doi: 10.3201/eid2703.204543. Epub 2020 Dec 22.
9
Healthcare worker infections and deaths due to COVID-19: A survey from 37 nations and a call for WHO to post national data on their website.医护人员因新冠病毒病感染及死亡情况:来自37个国家的调查以及呼吁世界卫生组织在其网站上公布各国数据
Int J Infect Dis. 2021 Jan;102:239-241. doi: 10.1016/j.ijid.2020.10.064. Epub 2020 Oct 29.
10
COVID-19-Lessons Learned and Questions Remaining.新冠病毒肺炎吸取的经验教训和遗留问题
Clin Infect Dis. 2021 Jun 15;72(12):2225-2240. doi: 10.1093/cid/ciaa1654.